This post will be closed automatically in 2026-06-22 22:17
Reward20points
journal：JAMA
Authors： ; Robert V. O’Toole; Nathan N. O’Hara; Anthony R. Carlini; Gregory M. Schrank; Suna Chung; Joshua L. Gary; William Obremskey; Paul Edward Matuszewski; David Teague; Roman M. Natoli; Ida Leah Gitajn; Michael J. Weaver; Christopher H. Renninger; Ashley Elizabeth Levack; Yasmin Degani; Susan C. Collins; Elias Weston-Farber; Andrea L. Howe; Richard E. Thompson; Renan C. Castillo; Madhav A. Karunakar; Laura Blum; Luke Harmer; Joseph R. Hsu; Laurence B. Kempton; Kevin D. Phelps; Rachel B. Seymour; Stephen H. Sims; Maithili S. Acharya; Hayden Callahan; Luz M. Chavez-Araujo; Christine Churchill; Michael P. Gambuzza; Kara R. Haim; Enosh Ishman; Joshua S. Kendall; Nicholas D. Mullis; Catherine Young; Holly T. Pilson; Eben A. Carroll; James Brett Goodman; Martha B. Holden; Alan L. Jones; Charles Moon; Carol A. Lin; Geoffrey S. Marecek; Gable B. Moffitt; Todd Conlan; Albert V. George; Lillian Adelaide Fisher; Devin S. Mullin; Chelsey L. Recendez; Arun Aneja; Devon T. Brameier; Marilyn Heng; Thuan V. Ly; Derek S. Stenquist; Nishant Suneja; Thirushan Wignakumar; Jacob S. Borgida; Thomas J. Policicchio; George R. Hanson; Olutayo M. Alese; William M. Ricci; Steve B. Behrens; Aleksey Dvorzhinskiy; Robert E. Bilodeau; Craig E. Klinger; Brian H. Mullis; Yohan Jang; Luke A. Lopas; Todd O. McKinley; Dillon C. O'Neill; Jan P. Szatkowski; Walter W. Virkus; Lauren C. Hill; Greg Gaski; Robert A. Hymes; James Ahn; Abraham M. Goch; Michael Holzman; A. Stephen Malekzadeh; Jeff E. Schulman; Jessica C. Rivera; Peter C. Krause; Carolyn Bridgman; Joseph Cohen; Carlo Eikani; Maria Chavez; Michelle Kudulis; Stephen J. Warner; Timothy S. Achor; Andrew Choo; Jonathan G. Eastman; Patrick J. Kellam; Sterling J. Boutte; Keyla Denniss Guevara; Kristoff R. Reid; Heather A. Vallier; Anna Vergon Tucci; Jana M. Davis; Alice C. Bell; Marissa E. Bonyun; Kathleen Healey; Vivian Li; Natasha S. McKibben; Jason Nascone; David Okhuereigbe; Marcus F. Sciadini; Gerard Slobogean; Nicolas Zingas; Murali Kovvur; Joshua E. Lawrence; Heather Phipps; Joshua Rudnicki; Kristin E. Turner; Roman Hayda; Andrew R. Evans; Stephen Quinnan; Alyha Benitez; Saqib Rehman; Melissa C. Soderquist; Clay B. Townsend; Cyrus Caroom; Angela C. Collins; Ebubechi Okwumabua; Humza S. Shaikh; Clay A. Spitler; Abhinav Agarwal; Michael D. Johnson; Justin M. Haller; Lucas S. Marchand; Nicholas A. Alfonso; Melissa A. Gorman; William Michael Charlton; Brandon R. Scott; Kameron M. Kraus; Sean J. Meredith; Sneh Talwar; Patrick F. Bergin; Aaradhana J. Jha; Sheketha McGee; Priyanka V. Nehete; Tyranny A. Pryor; Isaac Spears; Andrew T. Chen; Benjamin Kelley; Nevaeh R. Nez; William J. Ertl; Brandon R. Hull; Sarah Blumenthal; Joseph T. Patterson; Camille Flynn; Ryan C. Ross; Animesh Agarwal; David B. Weiss; Michael M. Hadeed; Seth R. Yarboro; Tina Daoud; Eric D. McVey; Paul S. Whiting; Christopher Domes; David C. Goodspeed; Gabrielle R. Kuhn; Robert Boyce; Andres Libos; Phillip M. Mitchell; Andres Fidel Moreno-Diaz; Robert Brandon Ponce; Daniel J. Stinner; Lauren M. Tatman; Juanita Velasco-Castro; Karen Trochez; Jibanananda Satpathy; David A. Zuelzer; Benjamin K. Potter
20
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma
